Eyal On-Dor
Haifa, HA, Israel
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Tumor Treating Fields (TTFields), and their concomitant application with FOLFOX, are effective for the treatment of gastric cancer cells.
Journal: Frontiers in oncology
Published: February 12, 2025
The transcriptomic fingerprint of cancer response to Tumor Treating Fields (TTFields).
Journal: Cell death discovery
Published: September 25, 2024
Tumor Treating Fields (TTFields) induce homologous recombination deficiency in ovarian cancer cells, thus mitigating drug resistance.
Journal: Frontiers in oncology
Published: March 18, 2024
Tumor Treating Fields (TTFields) demonstrate antiviral functions in vitro, and safety for application to COVID-19 patients in a pilot clinical study.
Journal: Frontiers in microbiology
Published: September 19, 2023
Tumor Treating Fields (TTFields) increase the effectiveness of temozolomide and lomustine in glioblastoma cell lines.
Journal: Journal of neuro-oncology
Published: March 07, 2023
Correction: Davidi et al. Tumor Treating Fields (TTFields) Concomitant with Sorafenib Inhibit Hepatocellular Carcinoma In Vitro and In Vivo. Cancers 2022, 14, 2959.
Journal: Cancers
Published: December 07, 2022
Tumor Treating Fields (TTFields) downregulate the Fanconi Anemia-BRCA pathway and increase the efficacy of chemotherapy in malignant pleural mesothelioma preclinical models.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: May 27, 2021
T-plastin is essential for basement membrane assembly and epidermal morphogenesis.
Journal: Science signaling
Published: June 01, 2017
Targeting glioblastoma via intranasal administration of Ff bacteriophages.
Journal: Frontiers in microbiology
Published: November 19, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026